YDES

YD Bio Limited Ordinary Shares (YDES)

Stock · NASDAQ · Health Care

$6.05as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

YDES Not Featured in Major Market Movers Lists. Recent market summaries from Benzinga and ChartMill highlighted other companies like Akamai and Scholastic, but YDES was not listed among the top gainers or losers. This suggests the stock did not experience significant price movement relative to the broader market during the reported period. The absence of specific news for this symbol indicates a quiet trading session without major corporate updates.

Active signals

Support level
$5.04
Industry
Medical Specialities

What YDES's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike4+11.9%50%
Any 20-session window (baseline)+27.4%68%

Computed by MarketWall from daily closing prices since June 11, 2026. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About YDES

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate sym…

Sector
Health Care
Industry
Medical Specialities
Employees
13

Fundamentals

1-day range
$5.82$7.05
Market cap
$167.45M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-0.03
Dividend yield
—
Beta
-0.25
Avg. volume
292.0K
52-week range
$1.7$22

YD Bio Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • YDES
    YD Bio Limited Ordinary Shares
    $5.92
    ▼ 12.17%
    Market cap $167.45MP/E —
    $1.7$22
  • XGN
    Exagen Inc. Common Stock
    $7.72
    ▼ 9.81%
    Market cap $159.64MP/E —
    $2.59$12.23
  • ACH
    Accendra Health Inc. Common Stock
    $0.24
    ▼ 7.69%
    Market cap $223.62MP/E —
    $0.2615$5.6
  • KEQU
    Kewaunee Scientific Corporation Common Stock
    $32.93
    ▲ 2.30%
    Market cap $108.73MP/E 11.26
    $32$46.57
  • BDSX
    Biodesix Inc. Common Stock
    $23.66
    ▼ 4.25%
    Market cap $228.86MP/E —
    $5.26$31.97
  • TLSIW
    TriSalus Life Sciences Inc. Warrant
    $0.8799
    ▼ 2.23%
    Market cap $101.95MP/E —
    $0.4405$1.85
  • BNR
    Burning Rock Biotech Limited American Depositary Shares
    $12.9
    ▼ 17.31%
    Market cap $93.65MP/E —
    $6.79$41.72

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
69.7K
Disposed
0

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.